Clinical Trials Phase I-IV utilizing Risk-Based Monitoring as applicable

Our Group makes the Drug Development process easier for you. By becoming your partner we execute your projects meticulously, with diligence and full attention. Our operating model allows us to be flexible and responsive to your changing needs, without compromising  communication, timelines and cost.
By offering a range of options, whether in full development programs or Phase-specific activities, we ensure that your goals in the Drug Development process are met.
We provide you with expert support in many therapeutic areas, including but not limited to:

  • CNS
  • Endocrinology/Metabolic Diseases
  • Immunology
  • Infectious Diseases
  • Oncology
  • Rare Diseases
  • Other (Anaesthesia, Cardiovascular, Dermatology, ENT, Gastroenterology, Haematology, Internal Medicine, Intensive Care Unit, Medical Devices, Neurology, Ophthalmology , Respiratory Diseases , Radiology/Imaging, Toxicology, and Urology)